Showing results (31-40 of 175) with videos related to
Sort By:
Pageof 18
Journal of Physiology, Paris|May 1, 1997
The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicksZ Grabarevic, M Tisljar, B Artukovic, et al.Pharmaceuticals (Basel, Switzerland)|April 27, 2024
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter ActivityPredrag Sikiric, Alenka Boban Blagaic, Sanja Strbe, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|June 15, 2017
Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in ratsS Vitaic, M Stupnisek, D Drmic, et al.Acta Physiologica Hungarica|January 1, 1992
The significance of the gastroprotective effect of body protection compound (BPC): modulation by different proceduresP Sikiric, M Petek, R Rucman, et al.Life Sciences|January 1, 1993
Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatinP Sikiric, S Seiwerth, Z Grabarevic, et al.Life Sciences|January 1, 1994
The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptidesP Sikiric, S Seiwerth, Z Grabarevic, et al.Thrombosis Research|August 16, 2011
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirinMirjana Stupnisek, Sandra Franjic, Domagoj Drmic, et al.Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as TherapySanja Strbe, Ivan Maria Smoday, Ivan Krezic, et al.Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A ReviewDanijel Matek, Irena Matek, Mladen Japjec, et al.Regulatory Peptides|November 12, 2009
Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injuryMiroslav Gjurasin, Pavle Miklic, Bozidar Zupancic, et al.Pageof 18